AstraZeneca board rejects sweetened takeover offer from Pfizer By Washington Examiner FacebookTwitterWhatsAppLinkedinEmailPrint May 2, 2014 9:56 am FacebookTwitterWhatsAppLinkedinEmailPrint LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer. TagsMergers and AcquisitionsPfizerPharmaceutical Industry Related Content Policy Paxton threatens action if YouTube charges subscribers $15 extra for Univision News Report: New Hampshire’s drug-related overdose fatalities plummet Immigration Pentagon will not furlough military troops stationed at US-Mexico border Columnists Thoughts on becoming an American this morning News Home affordability still an issue in Wisconsin
